Uncategorized Archives - Page 51 of 249

WednesdayJan 12, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Celebrates Productive Year for Blood Pressure Drug Solution with Eye on Advancing Clinical Studies in 2022

Lexaria Bioscience’s ongoing human clinical studies for its patented and trademarked DehydraTECH technology have yielded progressively optimistic results in 2021 regarding DehydraTECH’s ability to provide effective solutions for the cardiovascular industry DehydraTECH is being studied for its capacity to improve CBD’s ability to reduce high blood pressure in a rapid and sustainable manner that exceeds the ability of a generic CBD formulation DehydraTECH-CBD underwent three human clinical studies in 2021 that examined its ability to reduce arterial stiffness and blood pressure without creating unintended negative consequences A fourth, more comprehensive study was approved at year’s end, as the next step…

TuesdayJan 11, 2022 10:32 am

Q3 Report Notes Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Revenue Growth of 93 percent YOY

Red White & Bloom Brands is a cannabis multi-state operator building on opportunities in Michigan, Florida, Illinois, California, Arizona, Oklahoma and Massachusetts to create a synergistic portfolio throughout North America RWB is also building its hemp-based CBD products retail throughout the United States and into international markets The company has released its third quarter financial report on revenue growth, operational development and progress in finalizing additional agreements The report notes revenues grew from $6.1 million to $11.8 million year-over-year, largely as the result of its acquisition of its premium Platinum Vape The company anticipated having 30 grow pods in place…

MondayJan 10, 2022 12:47 pm

CannabisNewsWire Recaps NCIA’s 7th Annual Cannabis Business Summit & Expo

To great acclaim, the National Cannabis Industry Association (“NCIA”) held its 7th Annual Cannabis Business Summit & Expo at San Francisco’s Moscone Center on December 15-17, 2021. As the oldest and largest trade association representing legal cannabis businesses, NCIA gathered together more than 125 expert speakers in over 80 educational sessions, as well as hundreds of exhibitors from across the cannabis ecosystem, for the industry’s most influential B2B event and trade show. Attendees from across the country were welcomed by San Francisco Mayor, London Breed. Her opening address honored the 30th anniversary of the Proposition P ballot initiative, which was…

MondayJan 10, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Independent Review Board Approval for Its Most Ambitious, Comprehensive Human Study Yet

Lexaria has received approval from the Independent Review Board for its DehydraTECH-CBD Human Clinical HYPER-H21-4 study The approval signals the company has taken the appropriate steps to protect the rights and welfare of human subjects participating in its fourth human study HYPER-H21-4 should "de-risk" outcomes prior to Lexaria's planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular disease Previous studies – HYPER-H21-1 and HYPER-H21-2 – have evidenced a remarkable, rapid, and safe drop in blood pressure with DehydraTECH-CBD A little less than two months after Lexaria Bioscience (NASDAQ: LEXX) announced…

FridayJan 07, 2022 9:30 am

Flora Growth Corp. (NASDAQ: FLGC), a 2021 Year Review

2021 marked the year when Flora Growth held its IPO - the company’s common shares commenced trading on the Nasdaq Capital Market in May under the ticker symbol “FLGC" It also marked the year when the company ventured into the European market, as well as other key regions such as Mexico Significant acquisitions for the 2021 calendar year included Koch & Gsell, Vessel Brand Inc., and GMP-Certified Laboratory Flora Growth also made notable appointments to its executive leadership as well as its board of directors Flora Growth (NASDAQ: FLGC) had an impressive year in 2021, highlighted by the company’s Initial…

FridayJan 07, 2022 9:00 am

Sugarmade Inc. (SGMD) Subsidiary Obtains Permit, Takes Key Step Toward Commercialization

SGMD’s Lemon Glow receives conditional use permit number from county Sugarmade’s seed-to-door vision separates the company from other players in the California cannabis marketplace Estimated for Lemon Glow property could reach as much as 64 tons of dry trimmed cannabis flower annually Sugarmade (OTC: SGMD) is making significant progress toward its end goal of becoming a central play in the growing California cannabis space. The company announced that its wholly owned subsidiary, Lemon Glow Company, has received a conditional use permit (“UP”) number from the Community Development Department of the County of Lake, California (https://cnw.fm/Weujn). The permit, noted Sugarmade, is an…

ThursdayJan 06, 2022 9:30 am

Cannabis Strategic Ventures Inc. (NUGS) Strengthens Foothold as Mounting Numbers Support Cannabis Legalization

An estimated 91% of U.S. adults (91%) say either that marijuana should be legal for medical and recreational use or that it should be legal for medical use only While cannabis remains an illegal substance federally, a growing number of states have legalized the substance An emerging leader in the U.S. cannabis marketplace, NUGS’ vision is to acquire, scale assets in the legal cannabis market A vast majority of adults in the United States say that marijuana should be legal for either medical and recreational use or at least for medical use, according to a recent Pew Research Center report (https://cnw.fm/vsuui). Companies such…

ThursdayJan 06, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Increases Investor Visibility with SRAX Inc. (NASDAQ: SRAX)

The strategic move to incorporate SRAX is designed to bring investor visibility for all of the upcoming events that Lexaria has planned for 2022 Lexaria’s patented DehydraTECH(TM) technology is poised to leverage multiple industries – notably the CBD industry, with a projected value of $108.8 billion by 2027 The advertising and media contract will allow SRAX to engage and manage social media companies for the creation and distribution of advertising materials promoting Lexaria Bioscience Lexaria Bioscience (NASDAQ: LEXX), an innovator of drug delivery platforms, announced that it will kick off 2022 with an advertising and media agreement with SRAX (NASDAQ:…

WednesdayJan 05, 2022 1:07 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Named as One of the Top 101 Food and Beverage Startups and Companies in Canada

Best Startup Canada named BevCanna Enterprises one of the 101 Top Food and Beverage Startups and Companies in Canada BevCanna was also recognized as one of the Top 101 Cannabis Startups in the country The company has had strong growth momentum in its core business, with 3Q21 revenues rising over 1,000% year-over-year BevCanna signed an agreement to manufacture and white-label cannabis beverages on behalf of Averi Health Products, which will subsequently be distributed in the Canadian market BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) — a diversified health & wellness beverage and natural products company developing and manufacturing a…

WednesdayJan 05, 2022 12:22 pm

Sugarmade Inc.’s (SGMD) Nug Avenue Growth Fuels Expansion Plans

Nug Avenue success provides healthy backdrop as SGMD looks ahead to opening new locations In addition to adding members, Nug Avenue has added new cannabis delivery technology to its format New delivery tech provides everything from route optimization to real-time delivery updates, saving time and money while producing higher customer satisfaction Cannabis delivery continues to be a promising space in California — and around the country, for that matter— and the success of Sugarmade’s (OTC: SGMD) Nug Avenue firmly establishes the company as a leader in the growing sector (https://cnw.fm/DZscn). SGMD is leveraging the combination of Nug Avenue’s high performance and…